Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19

Abstract

The purpose of this short communication is to show that although photobiomodulation in the treatment of neurophathic oral pain after COVID-19 contagion could be an option, photobiomodulation is not a new technique. PBMT was used with different protocols and pain was assessed using VAS (visual analogue scale - 0 until 10) before and after the consultation. Results: Evolution of VAS during the sessions showed a decrease in painful symptomatology as treatment was performed. Conclusion: Based on the results obtained in the present case report, we concluded that PBMT with the parameters used in this clinical case was an effective, noninvasive and a new option of treatment for neuralgia resulting from COVID-19

Description

p. 1-5.: il. color.

Citation

GOMES, Fernanda Cruz Gonçalves et al. Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19. Braz Dent Sci, v. 4, supl. 1, p. 1-5, oct./dez. 2021.

Endorsement

Review

Supplemented By

Referenced By